Compile Data Set for Download or QSAR
Found 63 with Last Name = 'gammill' and Initial = 'rb'
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM554(5-cyano-N-{3-[(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-ph...)
Affinity DataKi:  0.00700nM ΔG°:  -63.0kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM558(N-{3-[(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  0.00800nM ΔG°:  -62.7kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM557(N-{3-[(1R)-1-[(6S)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  0.0180nM ΔG°:  -60.7kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM560(N-{3-[(1S)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  0.0320nM ΔG°:  -59.3kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM553(5-cyano-N-{3-[(1R)-1-[(6S)-4-hydroxy-2-oxo-6-(2-ph...)
Affinity DataKi:  0.0400nM ΔG°:  -58.8kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM550(N-{3-[(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  0.0600nM ΔG°:  -57.8kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM556(5-cyano-N-{3-[(1S)-1-[(6R)-4-hydroxy-2-oxo-6-(2-ph...)
Affinity DataKi:  0.100nM ΔG°:  -56.5kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM549(N-{3-[(1R)-1-[(6S)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  0.120nM ΔG°:  -56.1kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM555(5-cyano-N-{3-[(1S)-1-[(6S)-4-hydroxy-2-oxo-6-(2-ph...)
Affinity DataKi:  0.120nM ΔG°:  -56.1kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM559(N-{3-[(1S)-1-[(6S)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  0.220nM ΔG°:  -54.6kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM552(N-{3-[(1S)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  0.300nM ΔG°:  -53.8kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM551(N-{3-[(1S)-1-[(6S)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  1nM ΔG°:  -50.9kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM548(CHEMBL21188 | N-(3-{1-[4-hydroxy-2-oxo-6-(2-phenyl...)
Affinity DataKi:  1nM ΔG°:  -50.9kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM547(CHEMBL20846 | N-(3-{1-[4-hydroxy-2-oxo-6-(2-phenyl...)
Affinity DataKi:  3nM ΔG°:  -48.2kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM546(4-fluoro-N-(3-{1-[4-hydroxy-2-oxo-6-(2-phenylethyl...)
Affinity DataKi:  6nM ΔG°:  -46.5kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM545(4-cyano-N-(3-{1-[4-hydroxy-2-oxo-6-(2-phenylethyl)...)
Affinity DataKi:  8nM ΔG°:  -45.7kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM544(N-(3-{1-[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propy...)
Affinity DataKi:  17nM ΔG°:  -43.9kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044210(7-[2-(4-methylpiperazin-1-yl)ethoxy]-8-methyl-2-mo...)
Affinity DataIC50:  850nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcyl-CoA:cholesterol acyltransferase(Oryctolagus cuniculus)
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50228475(CHEMBL90348)
Affinity DataIC50:  1.12E+3nMAssay Description:In vitro inhibitory activity against Acyl coenzyme A:cholesterol acyltransferaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044219(6,8-Dimethyl-7-[2-(4-methyl-piperazin-1-yl)-ethoxy...)
Affinity DataIC50:  1.40E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044221(7-(1-tert-Butyl-1H-tetrazol-5-ylmethoxy)-8-methyl-...)
Affinity DataIC50:  2.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044183(7-(2-Diethylamino-ethoxy)-8-methyl-2-morpholin-4-y...)
Affinity DataIC50:  2.60E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044209(8-Methyl-7-(1-methyl-1H-tetrazol-5-ylmethoxy)-2-mo...)
Affinity DataIC50:  2.80E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044194(7-[2-(4-Methyl-piperazin-1-yl)-ethoxy]-2-morpholin...)
Affinity DataIC50:  3.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044204(7-(2-Azepan-1-yl-ethoxy)-8-methyl-2-morpholin-4-yl...)
Affinity DataIC50:  3.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044213(8-Ethyl-7-[2-(4-methyl-piperazin-1-yl)-ethoxy]-2-m...)
Affinity DataIC50:  4.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044215(8-Methyl-2-morpholin-4-yl-7-(2-pyrrolidin-1-yl-eth...)
Affinity DataIC50:  4.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044216(8-Methyl-2-morpholin-4-yl-7-(2-morpholin-4-yl-etho...)
Affinity DataIC50:  4.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044188(8-Methyl-2-morpholin-4-yl-7-(pyridin-3-ylmethoxy)-...)
Affinity DataIC50:  4.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044208(8-Methyl-2-morpholin-4-yl-7-(2-piperazin-1-yl-etho...)
Affinity DataIC50:  4.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcyl-CoA:cholesterol acyltransferase(Oryctolagus cuniculus)
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50228476(CHEMBL92580)
Affinity DataIC50:  4.18E+3nMAssay Description:In vitro inhibitory activity against Acyl coenzyme A:cholesterol acyltransferaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044207(8-Methyl-2-morpholin-4-yl-7-(2-thiomorpholin-4-yl-...)
Affinity DataIC50:  4.30E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044192(8-Methyl-2-morpholin-4-yl-7-(2-piperidin-1-yl-etho...)
Affinity DataIC50:  5.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcyl-CoA:cholesterol acyltransferase(Oryctolagus cuniculus)
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50228477(CHEMBL88725)
Affinity DataIC50:  5.77E+3nMAssay Description:In vitro inhibitory activity against Acyl coenzyme A:cholesterol acyltransferaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044217(7-(2-Methoxy-ethoxy)-8-methyl-2-morpholin-4-yl-chr...)
Affinity DataIC50:  7.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044185(8-Methyl-2-morpholin-4-yl-7-(1-phenyl-1H-tetrazol-...)
Affinity DataIC50:  8.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044200(8-Allyl-7-[2-(4-methyl-piperazin-1-yl)-ethoxy]-2-m...)
Affinity DataIC50:  8.90E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044186((8-Methyl-2-morpholin-4-yl-4-oxo-4H-chromen-7-ylox...)
Affinity DataIC50:  9.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044193(7-[2-(4-Benzyl-piperazin-1-yl)-ethoxy]-8-methyl-2-...)
Affinity DataIC50:  1.10E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044184(7-(1-Cyclohexyl-1H-tetrazol-5-ylmethoxy)-8-methyl-...)
Affinity DataIC50:  1.20E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044223(7-{2-[4-(2-Hydroxy-ethyl)-piperazin-1-yl]-ethoxy}-...)
Affinity DataIC50:  1.20E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044218(8-Methyl-2-morpholin-4-yl-7-(2-oxo-propoxy)-chrome...)
Affinity DataIC50:  1.20E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044189(8-Methyl-2-morpholin-4-yl-7-(naphthalen-1-ylmethox...)
Affinity DataIC50:  1.30E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcyl-CoA:cholesterol acyltransferase(Oryctolagus cuniculus)
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50228478(CHEMBL328228)
Affinity DataIC50: <1.33E+4nMAssay Description:In vitro inhibitory activity against Acyl coenzyme A:cholesterol acyltransferaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044190(8-Methyl-7-(2-methylsulfanyl-ethoxy)-2-morpholin-4...)
Affinity DataIC50:  1.40E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044214(7-{2-[Ethyl-(2-hydroxy-ethyl)-amino]-ethoxy}-8-met...)
Affinity DataIC50:  1.40E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044206(8-Methyl-2-morpholin-4-yl-7-(pyridin-2-ylmethoxy)-...)
Affinity DataIC50:  1.90E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044224(7-[2-(4-Methyl-piperazin-1-yl)-ethoxy]-2-morpholin...)
Affinity DataIC50:  3.50E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044197(7-(benzyloxy)-8-methyl-2-morpholino-4H-chromen-4-o...)
Affinity DataIC50:  4.00E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044191(7-Methoxy-8-methyl-2-morpholin-4-yl-chromen-4-one ...)
Affinity DataIC50:  4.10E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 63 total ) | Next | Last >>
Jump to: